Clinical Trial Update: Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating individualized locoregional treatment after primary systemic therapy for node-positive breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Breast Cancer | Phase 3 | Status: WITHDRAWN